This is a Validated Antibody Database (VAD) review about bovine NCAM1, based on 15 published articles (read how Labome selects the articles), using NCAM1 antibody in all methods. It is aimed to help Labome visitors find the most suited NCAM1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
others
  • flow cytometry; human; loading ...; fig 1
 NCAM1 antibody (Biolegend, MEM-188) was used in flow cytometry on human samples (fig 1). BMC Res Notes (2020) ncbi
 NCAM1 antibody (BioLegend, MEM-188) was used . Nat Commun (2019) ncbi
BioLegend
mouse monoclonal (MEM-188)
  • flow cytometry; human; loading ...; fig 1
BioLegend NCAM1 antibody (Biolegend, MEM-188) was used in flow cytometry on human samples (fig 1). BMC Res Notes (2020) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; loading ...; fig 6
BioLegend NCAM1 antibody (BioLegend, 304603) was used in flow cytometry on human samples (fig 6). Gastroenterol Res Pract (2019) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; loading ...; fig s8
BioLegend NCAM1 antibody (BioLegend, MEM-188) was used in flow cytometry on human samples (fig s8). Nat Commun (2019) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; loading ...; fig 1c, 4a
BioLegend NCAM1 antibody (BioLegend, 304604) was used in flow cytometry on human samples (fig 1c, 4a). J Exp Med (2018) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; loading ...; fig s1
BioLegend NCAM1 antibody (BioLegend, MEM-188) was used in flow cytometry on human samples (fig s1). J Clin Invest (2018) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; loading ...; fig s6
In order to study the role of leukocyte antigen F in and antigen presentation and immune response, BioLegend NCAM1 antibody (BioLegend, 304610) was used in flow cytometry on human samples (fig s6). Immunity (2017) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; 1:20; loading ...; fig 2b
BioLegend NCAM1 antibody (BioLegend, MEM-188) was used in flow cytometry on human samples at 1:20 (fig 2b). JCI Insight (2017) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; fig 3
BioLegend NCAM1 antibody (BioLegend, 304604) was used in flow cytometry on human samples (fig 3). Stem Cell Reports (2016) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; loading ...; fig 1
In order to identify cells that respond to interferon lambda, BioLegend NCAM1 antibody (Biolegend, MEM-188) was used in flow cytometry on human samples (fig 1). J Interferon Cytokine Res (2016) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; loading ...; fig s1c
In order to compare expression and function of the CD300 family of receptors between neonatal and adult immune cells, BioLegend NCAM1 antibody (BioLegend, MEM-188) was used in flow cytometry on human samples (fig s1c). Sci Rep (2016) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; loading ...
BioLegend NCAM1 antibody (Biolegend, MEM188) was used in flow cytometry on human samples . J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human; fig 3
In order to investigate the dynamics and characteristics of natural killer cell types in the human ocular mucosal surface in situ during infection with group D human adenoviruses, BioLegend NCAM1 antibody (Biolegend, MEM-188) was used in flow cytometry on human samples (fig 3). Mucosal Immunol (2016) ncbi
mouse monoclonal (MEM-188)
  • immunohistochemistry - paraffin section; human; fig 7
BioLegend NCAM1 antibody (BioLegend, MEM188) was used in immunohistochemistry - paraffin section on human samples (fig 7). Mol Cancer (2015) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human
In order to describe an Fc engineering approach that specifically affects antibody-dependent cytokine release, BioLegend NCAM1 antibody (Biolegend, 304612) was used in flow cytometry on human samples . MAbs (2015) ncbi
mouse monoclonal (MEM-188)
  • flow cytometry; human
BioLegend NCAM1 antibody (BioLegend, MEM-188) was used in flow cytometry on human samples . J Immunol (2014) ncbi
Articles Reviewed
  1. Deeba E, Lambrianides A, Pantzaris M, Krashias G, Christodoulou C. The expression profile of virus-recognizing toll-like receptors in natural killer cells of Cypriot multiple sclerosis patients. BMC Res Notes. 2020;13:460 pubmed publisher
  2. Xia Y, Gao Y, Wang B, Zhang H, Zhang Q. Optimizing the Method of Cell Separation from Bile of Patients with Cholangiocarcinoma for Flow Cytometry. Gastroenterol Res Pract. 2019;2019:5436961 pubmed publisher
  3. Pavel Dinu M, Wiebking V, Dejene B, Srifa W, Mantri S, Nicolas C, et al. Gene correction for SCID-X1 in long-term hematopoietic stem cells. Nat Commun. 2019;10:1634 pubmed publisher
  4. Kelly A, Günaltay S, McEntee C, Shuttleworth E, Smedley C, Houston S, et al. Human monocytes and macrophages regulate immune tolerance via integrin αvβ8-mediated TGFβ activation. J Exp Med. 2018;215:2725-2736 pubmed publisher
  5. Risnes L, Christophersen A, Dahal Koirala S, Neumann R, Sandve G, Sarna V, et al. Disease-driving CD4+ T cell clonotypes persist for decades in celiac disease. J Clin Invest. 2018;128:2642-2650 pubmed publisher
  6. Dulberger C, McMurtrey C, Hölzemer A, Neu K, Liu V, Steinbach A, et al. Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors. Immunity. 2017;46:1018-1029.e7 pubmed publisher
  7. Raposo R, de Mulder Rougvie M, Paquin Proulx D, Brailey P, Cabido V, Zdinak P, et al. IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis. JCI Insight. 2017;2:e85811 pubmed publisher
  8. Sugita S, Iwasaki Y, Makabe K, Kimura T, Futagami T, Suegami S, et al. Lack of T Cell Response to iPSC-Derived Retinal Pigment Epithelial Cells from HLA Homozygous Donors. Stem Cell Reports. 2016;7:619-634 pubmed publisher
  9. Kelly A, Robinson M, Roche G, Biron C, O Farrelly C, Ryan E. Immune Cell Profiling of IFN-? Response Shows pDCs Express Highest Level of IFN-?R1 and Are Directly Responsive via the JAK-STAT Pathway. J Interferon Cytokine Res. 2016;36:671-680 pubmed
  10. Zenarruzabeitia O, Vitallé J, Garcia Obregon S, Astigarraga I, Eguizabal C, Santos S, et al. The expression and function of human CD300 receptors on blood circulating mononuclear cells are distinct in neonates and adults. Sci Rep. 2016;6:32693 pubmed publisher
  11. Cerny D, Thi Le D, The T, Zuest R, Kg S, Velumani S, et al. Complete human CD1a deficiency on Langerhans cells due to a rare point mutation in the coding sequence. J Allergy Clin Immunol. 2016;138:1709-1712.e11 pubmed publisher
  12. Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed publisher
  13. Chang D, Moniz R, Xu Z, Sun J, Signoretti S, Zhu Q, et al. Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivo. Mol Cancer. 2015;14:119 pubmed publisher
  14. Kinder M, Greenplate A, Strohl W, Jordan R, Brezski R. An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functions. MAbs. 2015;7:494-504 pubmed publisher
  15. Lim D, Yawata N, Selva K, Li N, Tsai C, Yeong L, et al. The combination of type I IFN, TNF-α, and cell surface receptor engagement with dendritic cells enables NK cells to overcome immune evasion by dengue virus. J Immunol. 2014;193:5065-75 pubmed publisher